drugset / Trial / NCT01695824

Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial Fibrillation

NCT01695824

RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of this study is to assess combined end point (All stroke, Systemic embolism, Cardiovascular death) between two groups.

Timeline

Start
2011-12
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Warfarin Small molecule

Indications